Top

Reviews in Endocrine and Metabolic Disorders

Published in:

01-12-2017

Is there any role for minimally invasive surgery in NET?

Authors: M. Thomaschewski, H. Neeff, T. Keck, H. P. H. Neumann, T. Strate, E. von Dobschuetz

Published in: Reviews in Endocrine and Metabolic Disorders | Issue 4/2017

Abstract

Neuroendocrine tumors (NET) represent the variability of almost benign lesions either secreting hormones occurring as a single lesion up to malignant lesions with metastatic potential. Treatment of NET is usually performed by surgical resection. Due to the rarity of NET, surgical treatment is mainly based on the experience and recommendations of experts and less on the basis of prospective randomized studies. In addition, the development and establishment of new surgical procedures is made more difficult by their rarity. The development of laparoscopic-assisted surgery has significantly improved the treatment of many diseases. Due to the well-known advantages of laparoscopic surgery, this method has also been increasingly used to treat NET. However, due to limited comparative data, the assumed superiority of laparoscopic surgery in the area NET remains often unclear or not yet proven. This review focuses on the present usage of laparoscopic techniques in the area of NET. Relating to the current literature, this review presents the evidence of various laparoscopic procedures for treatment of adrenal, pancreatic and intestine NET as well as extraadrenal pheochromocytoma and neuroendocrine liver metastases. Further, this review focuses on recent new developments of minimally invasive surgery in the area of NET. Here, robotic-assisted surgery and single-port surgery are promising approaches.

Gagner M, Lacroix A, Bolte E. Laparoscopic adrenalectomy in Cushing's syndrome and pheochromocytoma. N Engl J Med. 1992;327(14):1033. https://doi.org/10.1056/NEJM199210013271417.PubMedCrossRef

Walz MK. Minimally invasive adrenal gland surgery. Transperitoneal or retroperitoneal approach? Chirurg. 2012;83(6):536–45. https://doi.org/10.1007/s00104-011-2194-5.PubMedCrossRef

Conzo G, Pasquali D, Della Pietra C, Napolitano S, Esposito D, Iorio S, et al. Laparoscopic adrenal surgery: ten-year experience in a single institution. BMC Surg. 2013;13(Suppl 2):S5. https://doi.org/10.1186/1471–2482-13-S2-S5.PubMedPubMedCentralCrossRef

Elfenbein DM, Scarborough JE, Speicher PJ, Scheri RP. Comparison of laparoscopic versus open adrenalectomy: results from American College of Surgeons-National Surgery Quality Improvement Project. J Surg Res. 2013;184(1):216–20. https://doi.org/10.1016/j.jss.2013.04.014.PubMedCrossRef

Tiberio GA, Baiocchi GL, Arru L, Agabiti Rosei C, De Ponti S, Matheis A, et al. Prospective randomized comparison of laparoscopic versus open adrenalectomy for sporadic pheochromocytoma. Surg Endosc. 2008;22(6):1435–9. https://doi.org/10.1007/s00464-008-9904-1.PubMedCrossRef

Walz MK, Peitgen K, Krause U, Eigler FW. Dorsal retroperitoneoscopic adrenalectomy--a new surgical technique. Zentralbl Chir. 1995;120(1):53–8.PubMed

Walz MK, Alesina PF, Wenger FA, Deligiannis A, Szuczik E, Petersenn S, et al. Posterior retroperitoneoscopic adrenalectomy--results of 560 procedures in 520 patients. Surgery. 2006;140(6):943–948. discussion 8–50. https://doi.org/10.1016/j.surg.2006.07.039.PubMedCrossRef

Berber E, Tellioglu G, Harvey A, Mitchell J, Milas M, Siperstein A. Comparison of laparoscopic transabdominal lateral versus posterior retroperitoneal adrenalectomy. Surgery. 2009;146(4):621–625. discussion 5–6. https://doi.org/10.1016/j.surg.2009.06.057.PubMedCrossRef

Mazzaglia PJ, Vezeridis MP. Laparoscopic adrenalectomy: balancing the operative indications with the technical advances. J Surg Oncol. 2010;101(8):739–44. https://doi.org/10.1002/jso.21565.PubMedCrossRef

10.

Tai CK, Li SK, Hou SM, Fan CW, Fung TC, Wah MK. Laparoscopic adrenalectomy: Comparison of lateral transperitoneal and lateral retroperitoneal approaches. Surg Laparosc Endosc Percutan Tech. 2006;16(3):141–5.PubMedCrossRef

11.

Ramacciato G, Nigri GR, Petrucciani N, Di Santo V, Piccoli M, Buniva P, et al. Minimally invasive adrenalectomy: a multicenter comparison of transperitoneal and retroperitoneal approaches. Am Surg. 2011;77(4):409–16.PubMed

12.

Kiriakopoulos A, Petralias A, Linos D. Posterior retroperitoneoscopic versus laparoscopic adrenalectomy in sporadic and MENIIA pheochromocytomas. Surg Endosc. 2015;29(8):2164–70. https://doi.org/10.1007/s00464-014-3912-0.PubMedCrossRef

13.

Dickson PV, Alex GC, Grubbs EG, Ayala-Ramirez M, Jimenez C, Evans DB, et al. Posterior retroperitoneoscopic adrenalectomy is a safe and effective alternative to transabdominal laparoscopic adrenalectomy for pheochromocytoma. Surgery. 2011;150(3):452–8. https://doi.org/10.1016/j.surg.2011.07.004.PubMedCrossRef

14.

Rubinstein M, Gill IS, Aron M, Kilciler M, Meraney AM, Finelli A, et al. Prospective, randomized comparison of transperitoneal versus retroperitoneal laparoscopic adrenalectomy. J Urol. 2005;174(2):442–445. discussion 5. https://doi.org/10.1097/01.ju.0000165336.44836.2d.PubMedCrossRef

15.

Bonjer HJ, Lange JF, Kazemier G, de Herder WW, Steyerberg EW, Bruining HA. Comparison of three techniques for adrenalectomy. Br J Surg. 1997;84(5):679–82.PubMedCrossRef

16.

Walz MK, Groeben H, Alesina PF. Single-access retroperitoneoscopic adrenalectomy (SARA) versus conventional retroperitoneoscopic adrenalectomy (CORA): a case-control study. World J Surg. 2010;34(6):1386–90. https://doi.org/10.1007/s00268-010-0494-4.PubMedCrossRef

17.

Kiriakopoulos A, Economopoulos KP, Poulios E, Linos D. Impact of posterior retroperitoneoscopic adrenalectomy in a tertiary care center: a paradigm shift. Surg Endosc. 2011;25(11):3584–9. https://doi.org/10.1007/s00464-011-1762-6.PubMedCrossRef

18.

Grau-Talens EJ, Garcia-Olives F, Ruperez-Arribas MP. Transcylindrical cholecystectomy: new technique for minimally invasive cholecystectomy. World J Surg. 1998;22(5):453–8.PubMedCrossRef

19.

Liatsikos E, Kallidonis P, Kyriazis I, Al-Aown A, Stolzenburg JU. Urologic laparoendoscopic single-site surgery. Nat Rev Urol. 2009;6(12):654–9. https://doi.org/10.1038/nrurol.2009.217.PubMedCrossRef

20.

Colleselli D, Janetschek G. Current trends in partial adrenalectomy. Curr Opin Urol. 2015;25(2):89–94. https://doi.org/10.1097/MOU.0000000000000147.PubMedCrossRef

21.

Wang L, Cai C, Liu B, Yang Q, Wu Z, Xiao L, et al. Perioperative outcomes and cosmesis analysis of patients undergoing laparoendoscopic single-site adrenalectomy: a comparison of transumbilical, transperitoneal subcostal, and retroperitoneal subcostal approaches. Urology. 2013;82(2):358–64. https://doi.org/10.1016/j.urology.2013.03.060.PubMedCrossRef

22.

Yuge K, Miyajima A, Hasegawa M, Miyazaki Y, Maeda T, Takeda T, et al. Initial experience of transumbilical laparoendoscopic single-site surgery of partial adrenalectomy in patient with aldosterone-producing adenoma. BMC Urol. 2010;10:19. https://doi.org/10.1186/1471-2490-10-19.PubMedPubMedCentralCrossRef

23.

St Julien J, Ball D, Schulick R. Robot-assisted cortical-sparing adrenalectomy in a patient with Von Hippel-Lindau disease and bilateral pheochromocytomas separated by 9 years. J Laparoendosc Adv Surg Tech A. 2006;16(5):473–7. https://doi.org/10.1089/lap.2006.16.473.PubMedCrossRef

24.

Nordenstrom E, Westerdahl J, Hallgrimsson P, Bergenfelz A. A prospective study of 100 roboticallyassisted laparoscopic adrenalectomies. J Robot Surg. 2011;5(2):127–31. https://doi.org/10.1007/s11701-011-0243-1.PubMedCrossRef

25.

Brandao LF, Autorino R, Laydner H, Haber GP, Ouzaid I, De Sio M, et al. Robotic versus laparoscopic adrenalectomy: a systematic review and meta-analysis. Eur Urol. 2014;65(6):1154–61. https://doi.org/10.1016/j.eururo.2013.09.021.PubMedCrossRef

26.

Economopoulos KP, Mylonas KS, Stamou AA, Theocharidis V, Sergentanis TN, Psaltopoulou T, et al. Laparoscopic versus robotic adrenalectomy: A comprehensive meta-analysis. Int J Surg. 2017;38:95–104. https://doi.org/10.1016/j.ijsu.2016.12.118.PubMedCrossRef

27.

Brunaud L, Ayav A, Zarnegar R, Rouers A, Klein M, Boissel P, et al. Prospective evaluation of 100 robotic-assisted unilateral adrenalectomies. Surgery. 2008;144(6):995–1001. discussion. https://doi.org/10.1016/j.surg.2008.08.032.PubMedCrossRef

28.

Berber E, Mitchell J, Milas M, Siperstein A. Robotic posterior retroperitoneal adrenalectomy: operative technique. Arch Surg. 2010;145(8):781–4. https://doi.org/10.1001/archsurg.2010.148.PubMedCrossRef

29.

Ludwig AT, Wagner KR, Lowry PS, Papaconstantinou HT, Lairmore TC. Robot-assisted posterior retroperitoneoscopic adrenalectomy. J Endourol. 2010;24(8):1307–14. https://doi.org/10.1089/end.2010.0152.PubMedCrossRef

30.

Okoh AK, Yigitbas H, Berber E. Robotic posterior retroperitoneal adrenalectomy. J Surg Oncol. 2015;112(3):302–4. https://doi.org/10.1002/jso.23909.PubMedCrossRef

31.

Taskin HE, Aliyev S, Aksoy E, Hamrahian A, Siperstein A, Berber E. Bilateral posterior retroperitoneal robotic adrenalectomy for ACTH-independent Cushing syndrome. Surg Laparosc Endosc Percutan Tech. 2014;24(3):e113–5. https://doi.org/10.1097/SLE.0b013e31828fa7da.PubMedCrossRef

32.

Kahramangil B, Berber E. Comparison of posterior retroperitoneal and transabdominal lateral approaches in robotic adrenalectomy: an analysis of 200 cases. Surg Endosc. 2017; https://doi.org/10.1007/s00464-017-5894-1.

33.

Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915–42. https://doi.org/10.1210/jc.2014-1498.PubMedCrossRef

34.

Pacak K. Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab. 2007;92(11):4069–79. https://doi.org/10.1210/jc.2007-1720.PubMedCrossRef

35.

Kinney MA, Narr BJ, Warner MA. Perioperative management of pheochromocytoma. J Cardiothorac Vasc Anesth. 2002;16(3):359–69.PubMedCrossRef

36.

Groeben H, Nottebaum BJ, Alesina PF, Traut A, Neumann HP, Walz MK. Perioperative alpha-receptor blockade in phaeochromocytoma surgery: an observational case series. Br J Anaesth. 2017;118(2):182–9. https://doi.org/10.1093/bja/aew392.PubMedCrossRef

37.

Livingstone M, Duttchen K, Thompson J, Sunderani Z, Hawboldt G, Sarah Rose M, et al. Hemodynamic Stability During Pheochromocytoma Resection: Lessons Learned Over the Last Two Decades. Ann Surg Oncol. 2015;22(13):4175–80. https://doi.org/10.1245/s10434-015-4519-y.PubMedCrossRef

38.

Kiernan CM, Du L, Chen X, Broome JT, Shi C, Peters MF, et al. Predictors of hemodynamic instability during surgery for pheochromocytoma. Ann Surg Oncol. 2014;21(12):3865–71. https://doi.org/10.1245/s10434-014-3847-7.PubMedPubMedCentralCrossRef

39.

Walz MK, Alesina PF, Wenger FA, Koch JA, Neumann HP, Petersenn S, et al. Laparoscopic and retroperitoneoscopic treatment of pheochromocytomas and retroperitoneal paragangliomas: results of 161 tumors in 126 patients. World J Surg. 2006;30(5):899–908. https://doi.org/10.1007/s00268-005-0373-6.PubMedCrossRef

40.

Rao N, Ramachandran R, Tandon N, Singh P, Kumar R. Laparoscopic adrenalectomy for pheochromocytoma-does size matter? A single surgeon comparative study. Transl Androl Urol. 2016;5(5):780–3. 10.21037/tau.2016.08.10.PubMedPubMedCentralCrossRef

41.

Carter YM, Mazeh H, Sippel RS, Chen H. Safety and feasibility of laparoscopic resection for large (>/= 6 CM) pheochromocytomas without suspected malignancy. Endocr Pract. 2012;18(5):720–6. https://doi.org/10.4158/EP12014.OR.PubMedPubMedCentralCrossRef

42.

Sessa L, Nomine-Criqui C, Germain A, Ayav A, Bresler L, Brunaud L. Robotic transperitoneal left adrenalectomy for a 10cm pheochromocytoma (with video). J Visc Surg. 2016;153(4):307–8. https://doi.org/10.1016/j.jviscsurg.2016.05.018.PubMedCrossRef

43.

Shen WT, Grogan R, Vriens M, Clark OH, Duh QY. One hundred two patients with pheochromocytoma treated at a single institution since the introduction of laparoscopic adrenalectomy. Arch Surg. 2010;145(9):893–7. https://doi.org/10.1001/archsurg.2010.159.PubMedCrossRef

44.

Goers TA, Abdo M, Moley JF, Matthews BD, Quasebarth M, Brunt LM. Outcomes of resection of extra-adrenal pheochromocytomas/paragangliomas in the laparoscopic era: a comparison with adrenal pheochromocytoma. Surg Endosc. 2013;27(2):428–33. https://doi.org/10.1007/s00464-012-2451-9.PubMedCrossRef

45.

Gagner M, Pomp A. Laparoscopic pylorus-preserving pancreatoduodenectomy. Surg Endosc. 1994;8(5):408–10.PubMedCrossRef

46.

Cuschieri A. Laparoscopic surgery of the pancreas. J R Coll Surg Edinb. 1994;39(3):178–84.PubMed

47.

Nigri GR, Rosman AS, Petrucciani N, Fancellu A, Pisano M, Zorcolo L, et al. Metaanalysis of trials comparing minimally invasive and open distal pancreatectomies. Surg Endosc. 2011;25(5):1642–51. https://doi.org/10.1007/s00464-010-1456-5.PubMedCrossRef

48.

Schloricke E, Hoffmann M, Kujath P, Shetty GM, Scheer F, Liedke MO, et al. Laparoscopic Pylorus- and Spleen-Preserving Duodenopancreatectomy for a Multifocal Neuroendocrine Tumor. Viszeralmedizin. 2015;31(5):364–9. https://doi.org/10.1159/000439335.PubMedPubMedCentral

49.

Mabrut JY, Fernandez-Cruz L, Azagra JS, Bassi C, Delvaux G, Weerts J, et al. Laparoscopic pancreatic resection: results of a multicenter European study of 127 patients. Surgery. 2005;137(6):597–605.PubMedCrossRef

50.

Wellner UF, Kusters S, Sick O, Busch C, Bausch D, Bronsert P, et al. Hybrid laparoscopic versus open pylorus-preserving pancreatoduodenectomy: retrospective matched case comparison in 80 patients. Langenbecks Arch Surg. 2014;399(7):849–56. https://doi.org/10.1007/s00423-014-1236-0.PubMedCrossRef

51.

Drymousis P, Raptis DA, Spalding D, Fernandez-Cruz L, Menon D, Breitenstein S, et al. Laparoscopic versus open pancreas resection for pancreatic neuroendocrine tumours: a systematic review and meta-analysis. HPB (Oxford). 2014;16(5):397–406. https://doi.org/10.1111/hpb.12162.PubMedCrossRef

52.

Fernandez-Cruz L, Blanco L, Cosa R, Rendon H. Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors? World J Surg. 2008;32(5):904–17. https://doi.org/10.1007/s00268-008-9467-2.PubMedCrossRef

53.

Partelli S, Bartsch DK, Capdevila J, Chen J, Knigge U, Niederle B, et al. ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours. Neuroendocrinology. 2017; https://doi.org/10.1159/000464292.

54.

Falconi M, Zerbi A, Crippa S, Balzano G, Boninsegna L, Capitanio V, et al. Parenchyma-preserving resections for small nonfunctioning pancreatic endocrine tumors. Ann Surg Oncol. 2010;17(6):1621–7. https://doi.org/10.1245/s10434-010-0949-8.PubMedCrossRef

55.

Zhao YP, Zhan HX, Zhang TP, Cong L, Dai MH, Liao Q, et al. Surgical management of patients with insulinomas: Result of 292 cases in a single institution. J Surg Oncol. 2011;103(2):169–74. https://doi.org/10.1002/jso.21773.PubMedCrossRef

56.

Partelli S, Tamburrino D, Lopez C, Albers M, Milanetto AC, Pasquali C, et al. Active Surveillance versus Surgery of Nonfunctioning Pancreatic Neuroendocrine Neoplasms </=2 cm in MEN1 Patients. Neuroendocrinology. 2016;103(6):779–86. https://doi.org/10.1159/000443613.PubMedCrossRef

57.

Fendrich V, Waldmann J, Bartsch DK, Langer P. Surgical management of pancreatic endocrine tumors. Nat Rev Clin Oncol. 2009;6(7):419–28. https://doi.org/10.1038/nrclinonc.2009.82.PubMedCrossRef

58.

Yoo YJ, Yang SJ, Hwang HK, Kang CM, Kim H, Lee WJ. Overestimated Oncologic Significance of Lymph Node Metastasis in G1 Nonfunctioning Neuroendocrine Tumor in the Left Side of the Pancreas. Medicine (Baltimore). 2015;94(36):e1404. https://doi.org/10.1097/MD.0000000000001404.PubMedPubMedCentralCrossRef

59.

Gagner M, Pomp A, Herrera MF. Early experience with laparoscopic resections of islet cell tumors. Surgery. 1996;120(6):1051–4.PubMedCrossRef

60.

Dedieu A, Rault A, Collet D, Masson B, Sa CA. Laparoscopic enucleation of pancreatic neoplasm. Surg Endosc. 2011;25(2):572–6. https://doi.org/10.1007/s00464-010-1223-7.PubMedCrossRef

61.

Zhang RC, Zhou YC, Mou YP, Huang CJ, Jin WW, Yan JF, et al. Laparoscopic versus open enucleation for pancreatic neoplasms: clinical outcomes and pancreatic function analysis. Surg Endosc. 2016;30(7):2657–65. https://doi.org/10.1007/s00464-015-4538-6.PubMedCrossRef

62.

Karaliotas C, Sgourakis G. Laparoscopic versus open enucleation for solitary insulinoma in the body and tail of the pancreas. J Gastrointest Surg. 2009;13(10):1869. https://doi.org/10.1007/s11605-009-0954-z.PubMedCrossRef

63.

Sa Cunha A, Beau C, Rault A, Catargi B, Collet D, Masson B. Laparoscopic versus open approach for solitary insulinoma. Surg Endosc. 2007;21(1):103–8. https://doi.org/10.1007/s00464-006-0021-8.PubMedCrossRef

64.

Costi R, Randone B, Mal F, Basato S, Levard H, Gayet B. A critical appraisal of laparoscopic pancreatic enucleations: right-sided procedures (Pancreatic Head, Uncus) are not mini-invasive surgery. Surg Laparosc Endosc Percutan Tech. 2013;23(6):524–31. https://doi.org/10.1097/SLE.0b013e31828e3d86.PubMedCrossRef

65.

Venkat R, Edil BH, Schulick RD, Lidor AO, Makary MA, Wolfgang CL. Laparoscopic distal pancreatectomy is associated with significantly less overall morbidity compared to the open technique: a systematic review and meta-analysis. Ann Surg. 2012;255(6):1048–59. https://doi.org/10.1097/SLA.0b013e318251ee09.PubMedCrossRef

66.

Sulpice L, Farges O, Goutte N, Bendersky N, Dokmak S, Sauvanet A, et al. Laparoscopic Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: Time for a Randomized Controlled Trial? Results of an All-inclusive National Observational Study. Ann Surg. 2015;262(5):868–873. discussion 73–4. https://doi.org/10.1097/SLA.0000000000001479.PubMedCrossRef

67.

de Rooij T, Jilesen AP, Boerma D, Bonsing BA, Bosscha K, van Dam RM, et al. A nationwide comparison of laparoscopic and open distal pancreatectomy for benign and malignant disease. J Am Coll Surg. 2015;220(3):263–270 e1. https://doi.org/10.1016/j.jamcollsurg.2014.11.010.PubMedCrossRef

68.

de Rooij T, Tol JA, van Eijck CH, Boerma D, Bonsing BA, Bosscha K, et al. Outcomes of distal pancreatectomy for pancreatic ductal adenocarcinoma in the Netherlands: a Nationwide retrospective analysis. Ann Surg Oncol. 2016;23(2):585–91. https://doi.org/10.1245/s10434-015-4930-4.PubMedCrossRef

69.

de Rooij T, van Hilst J, Busch OR, Dijkgraaf MG, Kooby DA, Abu Hilal M, et al. Laparoscopic distal pancreatectomy for pancreatic ductal adenocarcinoma: time for a randomized controlled trial? Results of an all-inclusive National Observational Study. Ann Surg. 2016; https://doi.org/10.1097/SLA.0000000000001710.

70.

de Rooij T, van Hilst J, Vogel JA, van Santvoort HC, de Boer MT, Boerma D, et al. Minimally invasive versus open distal pancreatectomy (LEOPARD): study protocol for a randomized controlled trial. Trials. 2017;18(1):166. https://doi.org/10.1186/s13063-017-1892-9. PubMedPubMedCentralCrossRef

71.

Lopez CL, Albers MB, Bollmann C, Manoharan J, Waldmann J, Fendrich V, et al. Minimally invasive versus open pancreatic surgery in patients with multiple endocrine neoplasia type 1. World J Surg. 2016;40(7):1729–36. https://doi.org/10.1007/s00268-016-3456-7.PubMedCrossRef

72.

Wang M, Meng L, Cai Y, Li Y, Wang X, Zhang Z, et al. Learning curve for laparoscopic Pancreaticoduodenectomy: a CUSUM analysis. J Gastrointest Surg. 2016;20(5):924–35. https://doi.org/10.1007/s11605-016-3105-3.PubMedCrossRef

73.

Song KB, Kim SC, Hwang DW, Lee JH, Lee DJ, Lee JW, et al. Matched case-control analysis comparing laparoscopic and open pylorus-preserving Pancreaticoduodenectomy in patients with Periampullary tumors. Ann Surg. 2015;262(1):146–55. https://doi.org/10.1097/SLA.0000000000001079.PubMedCrossRef

74.

Mendoza AS, 3rd, Han HS, Yoon YS, Cho JY, Choi Y. Laparoscopy-assisted pancreaticoduodenectomy as minimally invasive surgery for periampullary tumors: a comparison of short-term clinical outcomes of laparoscopy-assisted pancreaticoduodenectomy and open pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci 2015;22(12):819–824. doi:https://doi.org/10.1002/jhbp.289.

75.

Wang M, Zhang H, Wu Z, Zhang Z, Peng B. Laparoscopic pancreaticoduodenectomy: single-surgeon experience. Surg Endosc. 2015;29(12):3783–94. https://doi.org/10.1007/s00464-015-4154-5.PubMedCrossRef

76.

Keutgen XM, Hammel P, Choyke PL, Libutti SK, Jonasch E, Kebebew E. Evaluation and management of pancreatic lesions in patients with von Hippel-Lindau disease. Nat Rev Clin Oncol. 2016;13(9):537–49. https://doi.org/10.1038/nrclinonc.2016.37.PubMedCrossRef

77.

von Ducker L, Walz MK, Voss C, Arnold G, Eng C, Neumann HP. Laparoscopic organ-sparing resection of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors. World J Surg. 2011;35(3):563–7. https://doi.org/10.1007/s00268-010-0878-5.CrossRef

78.

Melvin WS, Needleman BJ, Krause KR, Schneider C, Wolf RK, Michler RE, et al. Computer-enhanced robotic telesurgery. Initial experience in foregut surgery. Surg Endosc. 2002;16(12):1790–2. https://doi.org/10.1007/s00464-001-8192-9.PubMedCrossRef

79.

Chen S, Zhan Q, Chen JZ, Jin JB, Deng XX, Chen H, et al. Robotic approach improves spleen-preserving rate and shortens postoperative hospital stay of laparoscopic distal pancreatectomy: a matched cohort study. Surg Endosc. 2015;29(12):3507–18. https://doi.org/10.1007/s00464-015-4101-5.PubMedCrossRef

80.

Daouadi M, Zureikat AH, Zenati MS, Choudry H, Tsung A, Bartlett DL, et al. Robot-assisted minimally invasive distal pancreatectomy is superior to the laparoscopic technique. Ann Surg. 2013;257(1):128–32. https://doi.org/10.1097/SLA.0b013e31825fff08.PubMedCrossRef

81.

Lee SY, Allen PJ, Sadot E, D'Angelica MI, DeMatteo RP, Fong Y, et al. Distal pancreatectomy: a single institution's experience in open, laparoscopic, and robotic approaches. J Am Coll Surg. 2015;220(1):18–27. https://doi.org/10.1016/j.jamcollsurg.2014.10.004.PubMedCrossRef

82.

Zhang J, Jin J, Chen S, Gu J, Zhu Y, Qin K, et al. Minimally invasive distal pancreatectomy for PNETs: laparoscopic or robotic approach? Oncotarget. 2017;8(20):33872–83. 10.18632/oncotarget.17513. PubMedPubMedCentral

83.

Lai EC, Tang CN. Robotic distal pancreatectomy versus conventional laparoscopic distal pancreatectomy: a comparative study for short-term outcomes. Front Med. 2015;9(3):356–60. https://doi.org/10.1007/s11684-015-0404-0.PubMedCrossRef

84.

Ryan CE, Ross SB, Sukharamwala PB, Sadowitz BD, Wood TW, Rosemurgy AS. Distal pancreatectomy and splenectomy: a robotic or LESS approach. JSLS. 2015;19(1):e2014 00246. https://doi.org/10.4293/JSLS.2014.00246.PubMedPubMedCentralCrossRef

85.

Joyce D, Morris-Stiff G, Falk GA, El-Hayek K, Chalikonda S, Walsh RM. Robotic surgery of the pancreas. World J Gastroenterol. 2014;20(40):14726–32. https://doi.org/10.3748/wjg.v20.i40.14726.PubMedPubMedCentralCrossRef

86.

Giulianotti PC, Addeo P, Buchs NC, Ayloo SM, Bianco FM. Robotic extended pancreatectomy with vascular resection for locally advanced pancreatic tumors. Pancreas. 2011;40(8):1264–70. https://doi.org/10.1097/MPA.0b013e318220e3a4.PubMedCrossRef

87.

Boone BA, Zenati M, Hogg ME, Steve J, Moser AJ, Bartlett DL, et al. Assessment of quality outcomes for robotic pancreaticoduodenectomy: identification of the learning curve. JAMA Surg. 2015;150(5):416–22. https://doi.org/10.1001/jamasurg.2015.17.PubMedCrossRef

88.

Hoffmann KM, Furukawa M, Jensen RT. Duodenal neuroendocrine tumors: classification, functional syndromes, diagnosis and medical treatment. Best Pract Res Clin Gastroenterol. 2005;19(5):675–97. https://doi.org/10.1016/j.bpg.2005.05.009.PubMedCrossRef

89.

Delle Fave G, O'Toole D, Sundin A, Taal B, Ferolla P, Ramage JK, et al. ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms. Neuroendocrinology. 2016;103(2):119–24. https://doi.org/10.1159/000443168.PubMedCrossRef

90.

Tsujimoto H, Ichikura T, Nagao S, Sato T, Ono S, Aiko S, et al. Minimally invasive surgery for resection of duodenal carcinoid tumors: endoscopic full-thickness resection under laparoscopic observation. Surg Endosc. 2010;24(2):471–5. https://doi.org/10.1007/s00464-009-0574-4.PubMedCrossRef

91.

Abe N, Takeuchi H, Shibuya M, Ohki A, Yanagida O, Masaki T, et al. Successful treatment of duodenal carcinoid tumor by laparoscopy-assisted endoscopic full-thickness resection with lymphadenectomy. Asian J Endosc Surg. 2012;5(2):81–5. https://doi.org/10.1111/j.1758-5910.2011.00120.x.PubMedCrossRef

92.

Shamiyeh A, Gabriel M. Laparoscopic resection of gastrointestinal neuroendocrine tumors with special contribution of radionuclide imaging. World J Gastroenterol. 2014;20(42):15608–15. https://doi.org/10.3748/wjg.v20.i42.15608.PubMedPubMedCentralCrossRef

93.

Jayakrishnan TT, Groeschl RT, George B, Thomas JP, Clark Gamblin T, Turaga KK. Review of the impact of antineoplastic therapies on the risk for cholelithiasis and acute cholecystitis. Ann Surg Oncol. 2014;21(1):240–7. https://doi.org/10.1245/s10434-013-3300-3.PubMedCrossRef

94.

Capurso G, Rinzivillo M, Bettini R, Boninsegna L, Delle Fave G, Falconi M. Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases. Br J Surg. 2012;99(11):1480–6. https://doi.org/10.1002/bjs.8842.PubMedCrossRef

95.

Connor SJ, Hanna GB, Frizelle FA. Appendiceal tumors: retrospective clinicopathologic analysis of appendiceal tumors from 7,970 appendectomies. Dis Colon rectum. 1998;41(1):75–80.PubMedCrossRef

96.

Alexandraki KI, Kaltsas GA, Grozinsky-Glasberg S, Chatzellis E, Grossman AB. Appendiceal neuroendocrine neoplasms: diagnosis and management. Endocr Relat Cancer. 2016;23(1):R27–41. https://doi.org/10.1530/ERC-15-0310.PubMedCrossRef

97.

Suarez-Grau JM, Garcia-Ruiz S, Rubio-Chaves C, Bustos-Jimenez M, Docobo-Durantez F, Padillo-Ruiz FJ. Appendiceal carcinoid tumors. Evaluation of long-term outcomes in a tertiary level. Cir Cir. 2014;82(2):142–9.PubMed

98.

Bucher P, Mathe Z, Demirag A, Morel P. Appendix tumors in the era of laparoscopic appendectomy. Surg Endosc. 2004;18(7):1063–6. https://doi.org/10.1007/s00464-003-9255-x. PubMedCrossRef

99.

Dralle H. Surgical strategies for accidental detection of appendix carcinoids. Chirurg. 2011;82(7):598–606. https://doi.org/10.1007/s00104-011-2071-2.PubMedCrossRef

100.

Abraham NS, Young JM, Solomon MJ. Meta-analysis of short-term outcomes after laparoscopic resection for colorectal cancer. Br J Surg. 2004;91(9):1111–24. https://doi.org/10.1002/bjs.4640.PubMedCrossRef

101.

Kuhry E, Schwenk WF, Gaupset R, Romild U, Bonjer HJ. Long-term results of laparoscopic colorectal cancer resection. Cochrane Database Syst Rev. 2008;2:CD003432. https://doi.org/10.1002/14651858.CD003432.pub2.

102.

Veldkamp R, Kuhry E, Hop WC, Jeekel J, Kazemier G, Bonjer HJ, et al. Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial. Lancet Oncol. 2005;6(7):477–84. https://doi.org/10.1016/S1470-2045(05)70221-7.PubMedCrossRef

103.

Jayne DG, Guillou PJ, Thorpe H, Quirke P, Copeland J, Smith AM, et al. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC trial group. J Clin Oncol. 2007;25(21):3061–8. https://doi.org/10.1200/JCO.2006.09.7758.PubMedCrossRef

104.

Palanivelu C, Rangarajan M, Annapoorni S, Senthilkumar R, Anand NV. Laparoscopic right hemicolectomy for goblet-cell carcinoid of the appendix: report of a rare case and literature survey. J Laparoendosc Adv Surg Tech A. 2008;18(3):417–21. https://doi.org/10.1089/lap.2007.0132.PubMedCrossRef

105.

Tomioka K, Fukoe Y, Lee Y, Lee M, Wada Y, Aoki T, et al. Primary neuroendocrine carcinoma of the appendix: a case report and review of the literature. Anticancer Res. 2013;33(6):2635–8.PubMed

106.

Scherubl H, Kloppel G. Rectal carcinoids on the rise - update. Z Gastroenterol. 2009;47(4):365–71. https://doi.org/10.1055/s-2008-1027930. PubMedCrossRef

107.

Konishi T, Watanabe T, Nagawa H, Oya M, Ueno M, Kuroyanagi H, et al. Treatment of colorectal carcinoids: a new paradigm. World J Gastrointest Surg. 2010;2(5):153–6. https://doi.org/10.4240/wjgs.v2.i5.153.PubMedPubMedCentralCrossRef

108.

Moore JS, Cataldo PA, Osler T, Hyman NH. Transanal endoscopic microsurgery is more effective than traditional transanal excision for resection of rectal masses. Dis Colon rectum. 2008;51(7):1026–1030. discussion 30-1. https://doi.org/10.1007/s10350-008-9337-x.PubMedCrossRef

109.

Quaresima S, Balla A, Franceschilli L, La Torre M, Iafrate C, Shalaby M, et al. Transanal minimally invasive surgery for rectal lesions. JSLS. 2016;20(3) https://doi.org/10.4293/JSLS.2016.00032.

110.

Atallah S, Albert M, Larach S. Transanal minimally invasive surgery: a giant leap forward. Surg Endosc. 2010;24(9):2200–5. https://doi.org/10.1007/s00464-010-0927-z.PubMedCrossRef

111.

Martin-Perez B, Andrade-Ribeiro GD, Hunter L, Atallah S. A systematic review of transanal minimally invasive surgery (TAMIS) from 2010 to 2013. Tech Coloproctol. 2014;18(9):775–88. https://doi.org/10.1007/s10151-014-1148-6.PubMedCrossRef

112.

Verseveld M, Barendse RM, Gosselink MP, Verhoef C, de Graaf EJ, Doornebosch PG. Transanal minimally invasive surgery: impact on quality of life and functional outcome. Surg Endosc. 2016;30(3):1184–7. https://doi.org/10.1007/s00464-015-4326-3.PubMedCrossRef

113.

Lee L, Burke JP, deBeche-Adams T, Nassif G, Martin-Perez B, Monson JR, et al. Transanal minimally invasive surgery for local excision of benign and malignant rectal neoplasia: outcomes from 200 consecutive cases with midterm follow up. Ann Surg. 2017; https://doi.org/10.1097/SLA.0000000000002190.

114.

Hahnloser D, Cantero R, Salgado G, Dindo D, Rega D, Delrio P. Transanal minimal invasive surgery for rectal lesions: should the defect be closed? Color Dis. 2015;17(5):397–402. https://doi.org/10.1111/codi.12866.CrossRef

115.

Janebdar H, Malik A. Transanal minimally invasive surgery (TAMIS) for excision of rectal carcinoid - video vignette. Color Dis. 2017; https://doi.org/10.1111/codi.13685.

116.

McDermott FD, Heeney A, Courtney D, Mohan H, Winter D. Rectal carcinoids: a systematic review. Surg Endosc. 2014;28(7):2020–6. https://doi.org/10.1007/s00464-014-3430-0.PubMedCrossRef

117.

Ramage JK, Goretzki PE, Manfredi R, Komminoth P, Ferone D, Hyrdel R, et al. Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated colon and rectum tumour/carcinoma. Neuroendocrinology. 2008;87(1):31–9. https://doi.org/10.1159/000111036. PubMedCrossRef

118.

Scherubl H, de Mestier L, Cadiot G. Therapy of rectal carcinoids of 11 to 19 mm: a matter of debate. Gastrointest Endosc. 2014;80(3):532–3. https://doi.org/10.1016/j.gie.2014.03.009.PubMedCrossRef

119.

Breukink SO, van der Zaag-Loonen HJ, Bouma EM, Pierie JP, Hoff C, Wiggers T, et al. Prospective evaluation of quality of life and sexual functioning after laparoscopic total mesorectal excision. Dis Colon rectum. 2007;50(2):147–55. https://doi.org/10.1007/s10350-006-0791-z. PubMedCrossRef

120.

Bonjer HJ, Deijen CL, Abis GA, Cuesta MA, van der Pas MH, de Lange-de Klerk ES, et al. A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med. 2015;372(14):1324–32. https://doi.org/10.1056/NEJMoa1414882.PubMedCrossRef

121.

Jeong SY, Park JW, Nam BH, Kim S, Kang SB, Lim SB, et al. Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. Lancet Oncol. 2014;15(7):767–74. https://doi.org/10.1016/S1470-2045(14)70205-0.PubMedCrossRef

122.

Takatsu Y, Fukunaga Y, Nagasaki T, Akiyoshi T, Konishi T, Fujimoto Y, et al. Short- and long-term outcomes of laparoscopic Total mesenteric excision for neuroendocrine tumors of the rectum. Dis Colon rectum. 2017;60(3):284–9. https://doi.org/10.1097/DCR.0000000000000745. PubMed

123.

Kim MJ, Park SC, Park JW, Chang HJ, Kim DY, Nam BH, et al. Robot-assisted versus laparoscopic surgery for rectal cancer: a phase II open label prospective randomized controlled trial. Ann Surg. 2017; https://doi.org/10.1097/SLA.0000000000002321.

124.

Frilling A, Li J, Malamutmann E, Schmid KW, Bockisch A, Broelsch CE. Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease. Br J Surg. 2009;96(2):175–84. https://doi.org/10.1002/bjs.6468.PubMedCrossRef

125.

Glazer ES, Tseng JF, Al-Refaie W, Solorzano CC, Liu P, Willborn KA, et al. Long-term survival after surgical management of neuroendocrine hepatic metastases. HPB (Oxford). 2010;12(6):427–33. https://doi.org/10.1111/j.1477-2574.2010.00198.x.CrossRef

126.

Frilling A, Clift AK. Therapeutic strategies for neuroendocrine liver metastases. Cancer. 2015;121(8):1172–86. https://doi.org/10.1002/cncr.28760.PubMedCrossRef

127.

Watzka FM, Fottner C, Miederer M, Schad A, Weber MM, Otto G, et al. Surgical therapy of neuroendocrine neoplasm with hepatic metastasis: patient selection and prognosis. Langenbeck's Arch Surg. 2015;400(3):349–58. https://doi.org/10.1007/s00423-015-1277-z.CrossRef

128.

Kandil E, Saeed A, Buell J. Surgical approaches for liver metastases in carcinoid tumors. Gland Surg. 2015;4(5):442–6. https://doi.org/10.3978/j.issn.2227-684X.2015.04.10. PubMedPubMedCentral

129.

Fairweather M, Swanson R, Wang J, Brais LK, Dutton T, Kulke MH, et al. Management of Neuroendocrine Tumor Liver Metastases: long-term outcomes and prognostic factors from a large prospective database. Ann Surg Oncol. 2017; https://doi.org/10.1245/s10434-017-5839-x.

130.

Conrad C, Ogiso S, Inoue Y, Shivathirthan N, Gayet B. Laparoscopic parenchymal-sparing liver resection of lesions in the central segments: feasible, safe, and effective. Surg Endosc. 2015;29(8):2410–7. https://doi.org/10.1007/s00464-014-3924-9.PubMedCrossRef

131.

Zorzi D, Laurent A, Pawlik TM, Lauwers GY, Vauthey JN, Abdalla EK. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg. 2007;94(3):274–86. https://doi.org/10.1002/bjs.5719.PubMedCrossRef

132.

Jaeck D, Oussoultzoglou E, Bachellier P, Lemarque P, Weber JC, Nakano H, et al. Hepatic metastases of gastroenteropancreatic neuroendocrine tumors: safe hepatic surgery. World J Surg. 2001;25(6):689–92.PubMedCrossRef

133.

Kianmanesh R, Sauvanet A, Hentic O, Couvelard A, Levy P, Vilgrain V, et al. Two-step surgery for synchronous bilobar liver metastases from digestive endocrine tumors: a safe approach for radical resection. Ann Surg. 2008;247(4):659–65. https://doi.org/10.1097/SLA.0b013e31816a7061.PubMedCrossRef

134.

Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012;255(3):405–14. https://doi.org/10.1097/SLA.0b013e31824856f5.PubMedCrossRef

135.

Kandil E, Noureldine SI, Koffron A, Yao L, Saggi B, Buell JF. Outcomes of laparoscopic and open resection for neuroendocrine liver metastases. Surgery. 2012;152(6):1225–31. https://doi.org/10.1016/j.surg.2012.08.027.PubMedCrossRef

136.

Abu Hilal M, Di Fabio F, Abu Salameh M, Pearce NW. Oncological efficiency analysis of laparoscopic liver resection for primary and metastatic cancer: a single-center UK experience. Arch Surg. 2012;147(1):42–8. https://doi.org/10.1001/archsurg.2011.856.PubMedCrossRef

137.

Cipriani F, Rawashdeh M, Stanton L, Armstrong T, Takhar A, Pearce NW, et al. Propensity score-based analysis of outcomes of laparoscopic versus open liver resection for colorectal metastases. Br J Surg. 2016;103(11):1504–12. https://doi.org/10.1002/bjs.10211.PubMedCrossRef

138.

Massironi S, Conte D, Sciola V, Pirola L, Paggi S, Fraquelli M, et al. Contrast-enhanced ultrasonography in evaluating hepatic metastases from neuroendocrine tumours. Dig Liver Dis. 2010;42(9):635–41. https://doi.org/10.1016/j.dld.2010.01.009.PubMedCrossRef

139.

Spolverato G, Bagante F, Aldrighetti L, Poultsides GA, Bauer TW, Fields RC, et al. Management and outcomes of patients with recurrent neuroendocrine liver metastasis after curative surgery: an international multi-institutional analysis. J Surg Oncol. 2017; https://doi.org/10.1002/jso.24670.

Title: Is there any role for minimally invasive surgery in NET?
Authors: M. Thomaschewski
H. Neeff
T. Keck
H. P. H. Neumann
T. Strate
E. von Dobschuetz
Publication date: 01-12-2017
Publisher: Springer US
Published in: Reviews in Endocrine and Metabolic Disorders / Issue 4/2017
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI: https://doi.org/10.1007/s11154-017-9436-x

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2017

Hormone secreting gastro-entero-pancreatic neuroendocrine neoplasias (GEP-NEN): When to consider, how to diagnose?

Echocardiography in functional midgut neuroendocrine tumors: When and how often

Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy

Chemotherapy in NETs: When and how

When should genetic testing be performed in patients with neuroendocrine tumours?

Liver transarterial embolizations in metastatic neuroendocrine tumors

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage